FIU20060296U0 - Förfaranden för minskande av alkoholinducerad dosutlösning för orala opioiddoserformer med fördröjd frigöring - Google Patents

Förfaranden för minskande av alkoholinducerad dosutlösning för orala opioiddoserformer med fördröjd frigöring

Info

Publication number
FIU20060296U0
FIU20060296U0 FI20060296U FIU20060296U FIU20060296U0 FI U20060296 U0 FIU20060296 U0 FI U20060296U0 FI 20060296 U FI20060296 U FI 20060296U FI U20060296 U FIU20060296 U FI U20060296U FI U20060296 U0 FIU20060296 U0 FI U20060296U0
Authority
FI
Finland
Prior art keywords
opioids
long
dosage forms
oral dosage
induced dose
Prior art date
Application number
FI20060296U
Other languages
English (en)
Finnish (fi)
Inventor
Gayatri Sathyan
Nipun Davar
Linda H Pors
Gemma Casadevall
Jayne Hastedt
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of FIU20060296U0 publication Critical patent/FIU20060296U0/sv
Application granted granted Critical
Publication of FI7357U1 publication Critical patent/FI7357U1/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI20060296U 2005-10-31 2006-07-12 Förfaranden för minskande av alkoholinducerad dosutlösning för orala opioiddoserformer med fördröjd frigöring FI7357U1 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73199505P 2005-10-31 2005-10-31
US80201706P 2006-05-18 2006-05-18

Publications (2)

Publication Number Publication Date
FIU20060296U0 true FIU20060296U0 (sv) 2006-07-12
FI7357U1 FI7357U1 (sv) 2007-01-16

Family

ID=36758362

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20060296U FI7357U1 (sv) 2005-10-31 2006-07-12 Förfaranden för minskande av alkoholinducerad dosutlösning för orala opioiddoserformer med fördröjd frigöring

Country Status (11)

Country Link
BG (1) BG1070U1 (sv)
CA (6) CA2554684A1 (sv)
CZ (1) CZ19137U1 (sv)
DK (1) DK200600189U3 (sv)
FI (1) FI7357U1 (sv)
GB (1) GB0612326D0 (sv)
IE (1) IES20060507A2 (sv)
NL (1) NL1032148C1 (sv)
NO (1) NO20063233L (sv)
SE (1) SE0601589L (sv)
SK (1) SK5202Y1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2692437T3 (es) 2007-08-13 2018-12-03 Abuse Deterrent Pharmaceutical Llc Fármacos resistentes al abuso, método de uso y método de preparación
US20140275149A1 (en) 2013-03-15 2014-09-18 Inspirion Delivery Technologies, Llc Abuse deterrent compositions and methods of use
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
US10172842B2 (en) * 2015-09-11 2019-01-08 PharmaDax Inc. Sustained release oral dosage form containing dalfampridine

Also Published As

Publication number Publication date
GB0612326D0 (en) 2006-08-02
CA2554874A1 (en) 2007-04-30
CZ19137U1 (cs) 2008-12-08
CA2554693A1 (en) 2007-04-30
DK200600189U3 (da) 2007-02-23
FI7357U1 (sv) 2007-01-16
SK5202Y1 (en) 2009-06-05
BG1070U1 (bg) 2008-06-30
SK50572006U1 (en) 2009-01-07
IES20060507A2 (en) 2007-05-30
CA2554684A1 (en) 2007-04-30
NO20063233L (no) 2007-05-02
CA2554697A1 (en) 2007-04-30
CA2554701A1 (en) 2007-04-30
SE0601589L (sv) 2007-05-01
NL1032148C1 (nl) 2006-11-17
CA2554698A1 (en) 2007-04-30

Similar Documents

Publication Publication Date Title
HUP0600816A2 (en) Method of alcohol-induced dose dumping for opioid sustained release oral dosage forms
PT3072504T (pt) Formas de dosagem transmucosa oral de pequeno volume
IL187330A0 (en) A method of marking composition for oral administration
ME01550B (me) Farmaceutski dozni oblici
IL206159A0 (en) Oral pharmaceutical dosage forms
IL194277A0 (en) Solid oral dosage form containing an enhancer
EP2040731A4 (en) SOLID DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING AN ACTIVATOR
IL198753A0 (en) Oral transmucosal nicotine dosage form
FI7357U1 (sv) Förfaranden för minskande av alkoholinducerad dosutlösning för orala opioiddoserformer med fördröjd frigöring
IL195822A0 (en) Segmented pharmaceutical dosage forms
GB0616703D0 (en) Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
GB0403808D0 (en) Films for use as dosage forms
ZA200804734B (en) Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
PL373776A1 (en) Oral pharmaceutical compound
SE0602280L (sv) Förfaranden för minskning av alkoholinducerad dosdumpning för orala opioiddosformer med fördröjt frisättande
ZA200810270B (en) Segmented pharmaceutical dosage forms
EP1793848A4 (en) METHOD OF DETERMINING A DOSAGE FOR ORAL INACTIVE VACCINE
ITRG20030001A1 (it) Apparecchio cloro-vortex per dosaggio ipoclorito
PL364615A1 (en) Method for purification of quinapril hydrochloride
IL177451A0 (en) Crystalline forms of a pharmaceutical compound
HK1102087A1 (en) Crystalline forms of a pharmaceutical compound

Legal Events

Date Code Title Description
FGU Utility model registered

Ref document number: 7357

Country of ref document: FI

MAU Utility model expired